Signaling through Up-Regulated C3a Receptor Is Key to the Development of Experimental Lupus Nephritis1
暂无分享,去创建一个
[1] J. Köhl,et al. The anaphylatoxins bridge innate and adaptive immune responses in allergic asthma. , 2004, Molecular immunology.
[2] J. Gelfand,et al. Interleukin-1 upregulates anaphylatoxin receptors on mononuclear cells. , 2004, Surgery.
[3] R. Gutzmer,et al. Human monocyte‐derived dendritic cells are chemoattracted to C3a after up‐regulation of the C3a receptor with interferons , 2004, Immunology.
[4] D. Fruman,et al. Phosphoinositide 3-kinase: diverse roles in immune cell activation. , 2004, Annual review of immunology.
[5] W. Lieberthal,et al. Role of apoptosis of renal tubular cells in acute renal failure: Therapeutic implications , 2001, Apoptosis.
[6] G. Gilkeson,et al. Effects of complement factor D deficiency on the renal disease of MRL/lpr mice. , 2004, Kidney international.
[7] G. Zandman-Goddard,et al. [Apoptosis in systemic lupus erythematosus]. , 2003, Harefuah.
[8] R. Quigg,et al. Excessive matrix accumulation in the kidneys of MRL/lpr lupus mice is dependent on complement activation. , 2003, Journal of the American Society of Nephrology : JASN.
[9] M. Sulis,et al. PTEN: from pathology to biology. , 2003, Trends in cell biology.
[10] J. Woodgett,et al. Unravelling the activation mechanisms of protein kinase B/Akt , 2003, FEBS letters.
[11] S. Baksh,et al. Apoptotic Cells Induce Migration of Phagocytes via Caspase-3-Mediated Release of a Lipid Attraction Signal , 2003, Cell.
[12] P. Gasque,et al. Regulation by complement C3a and C5a anaphylatoxins of cytokine production in human umbilical vein endothelial cells , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[13] B. Morgan,et al. Beyond lysis: how complement influences cell fate. , 2003, Clinical science.
[14] J. Köhl,et al. Complement Factor C5a Mediates Renal Ischemia-Reperfusion Injury Independent from Neutrophils1 , 2003, The Journal of Immunology.
[15] V. Kelley,et al. Reduced Macrophage Recruitment, Proliferation, and Activation in Colony-Stimulating Factor-1-Deficient Mice Results in Decreased Tubular Apoptosis During Renal Inflammation 1 , 2003, The Journal of Immunology.
[16] R. Quigg,et al. Administration of a soluble recombinant complement C3 inhibitor protects against renal disease in MRL/lpr mice. , 2003, Journal of the American Society of Nephrology : JASN.
[17] P. Heeringa,et al. Inhibition of complement factor C5 protects against renal ischemia-reperfusion injury: inhibition of late apoptosis and inflammation1 , 2003, Transplantation.
[18] C. Gerard. Complement C5a in the sepsis syndrome--too much of a good thing? , 2003, The New England journal of medicine.
[19] N. Riedemann,et al. The FASEB Journal express article 10.1096/fj.02-0033fje. Published online April 23, 2002. C5a receptor and thymocyte apoptosis in sepsis , 2022 .
[20] J. Alexander,et al. Transgenic Expression of a Soluble Complement Inhibitor Protects Against Renal Disease and Promotes Survival in MRL/lpr Mice1 , 2002, The Journal of Immunology.
[21] B. van de Water,et al. The membrane attack complex of complement induces caspase activation and apoptosis , 2002, European journal of immunology.
[22] M. Walport,et al. C1q Deficiency and Autoimmunity: The Effects of Genetic Background on Disease Expression1 , 2000, The Journal of Immunology.
[23] I. McInnes,et al. A Proinflammatory Role of IL-18 in the Development of Spontaneous Autoimmune Disease1 , 2001, The Journal of Immunology.
[24] V. Cattell,et al. Cutting Edge: Amelioration of Kidney Disease in a Transgenic Mouse Model of Lupus Nephritis by Administration of the Caspase Inhibitor Carbobenzoxy-Valyl-Alanyl-Aspartyl-(β-o-methyl)-Fluoromethylketone1 , 2001, The Journal of Immunology.
[25] J. Köhl,et al. Anaphylatoxins and infectious and non-infectious inflammatory diseases. , 2001, Molecular immunology.
[26] J. Adams,et al. Identification of a Selective Nonpeptide Antagonist of the Anaphylatoxin C3a Receptor That Demonstrates Antiinflammatory Activity in Animal Models , 2001, The Journal of Immunology.
[27] V. M. Holers,et al. Complement Component C3 Is Not Required for Full Expression of Immune Complex Glomerulonephritis in MRL/lpr Mice , 2001, The Journal of Immunology.
[28] M. Walport. Complement. First of two parts. , 2001, The New England journal of medicine.
[29] J. Fortenberry,et al. Neutrophils induce apoptosis of lung epithelial cells via release of soluble Fas ligand. , 2001, American journal of physiology. Lung cellular and molecular physiology.
[30] O. Götze,et al. Activated Human T Lymphocytes Express a Functional C3a Receptor1 , 2000, The Journal of Immunology.
[31] F. Murad,et al. Cutting Edge: Targeted Disruption of the C3a Receptor Gene Demonstrates a Novel Protective Anti-Inflammatory Role for C3a in Endotoxin-Shock1 , 2000, The Journal of Immunology.
[32] D. Loskutoff,et al. Expression of Transforming Growth Factor-β and Tumor Necrosis Factor-α in the Plasma and Tissues of Mice with Lupus Nephritis , 2000, Laboratory Investigation.
[33] C. Smythe,et al. Treatment of murine lupus with cDNA encoding IFN-?R/Fc , 2000 .
[34] Bao Lu,et al. A role for the C3a anaphylatoxin receptor in the effector phase of asthma , 2000, Nature.
[35] S. Schwartz,et al. Fas/FADD-mediated activation of a specific program of inflammatory gene expression in vascular smooth muscle cells , 2000, Nature Medicine.
[36] C. Alpers,et al. C5b-9 membrane attack complex mediates endothelial cell apoptosis in experimental glomerulonephritis. , 2000, American journal of physiology. Renal physiology.
[37] M. Vendelin,et al. Regulation of mitochondrial respiration in heart cells analyzed by reaction-diffusion model of energy transfer. , 2000, American journal of physiology. Cell physiology.
[38] K. Okumura,et al. Treatment of lupus in NZB/W F1 mice with monoclonal antibody against Fas ligand. , 2000, Journal of autoimmunity.
[39] D. Kono,et al. Treatment of murine lupus with cDNA encoding IFN-γR/Fc , 2000 .
[40] H. Colten,et al. Modulation of Renal Disease in MRL/lpr Mice Genetically Deficient in the Alternative Complement Pathway Factor B1 , 2000, The Journal of Immunology.
[41] B. Pussell,et al. C3a is made by proximal tubular HK-2 cells and activates them via the C3a receptor. , 1999, Kidney international.
[42] A. Theofilopoulos,et al. Tumour necrosis factor and other cytokines in murine lupus , 1999, Annals of the rheumatic diseases.
[43] J. Schelling,et al. Involvement of Fas-dependent apoptosis in renal tubular epithelial cell deletion in chronic renal failure. , 1999, Kidney international.
[44] D. Haskard,et al. TNF-alpha and IL-1 sequentially induce endothelial ICAM-1 and VCAM-1 expression in MRL/lpr lupus-prone mice. , 1999, Journal of immunology.
[45] P. Vandenabeele,et al. Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation. , 1999, The Journal of clinical investigation.
[46] L. Cantley,et al. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[47] F. Huang,et al. Modulation of autoimmune disease in the MRL-lpr/lpr mouse by IL-2 and TGF-β1 gene therapy using attenuated Salmonella typhimurium as gene carrier , 1999, Lupus.
[48] D. Haskard,et al. TNF-α and IL-1 Sequentially Induce Endothelial ICAM-1 and VCAM-1 Expression in MRL/lpr Lupus-Prone Mice , 1999, The Journal of Immunology.
[49] K. Moore,et al. Gene transfer of RANTES elicits autoimmune renal injury in MRL-Fas(1pr) mice. , 1998, Kidney international.
[50] Pier Paolo Pandolfi,et al. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies , 1998, Nature Genetics.
[51] J. Alexander,et al. Immune complex glomerulonephritis in C4- and C3-deficient mice. , 1998, Kidney international.
[52] David Garrick,et al. Repeat-induced gene silencing in mammals , 1998, Nature Genetics.
[53] Asim Khwaja,et al. Matrix adhesion and Ras transformation both activate a phosphoinositide 3‐OH kinase and protein kinase B/Akt cellular survival pathway , 1997, The EMBO journal.
[54] A. Ganser,et al. The Human C3a Receptor Is Expressed on Neutrophils and Monocytes, but Not on B or T Lymphocytes , 1997, The Journal of experimental medicine.
[55] M. Giacca,et al. C–C Chemokines Released by Lipopolysaccharide (LPS)-stimulated Human Macrophages Suppress HIV-1 Infection in Both Macrophages and T Cells , 1997, The Journal of experimental medicine.
[56] G. Evan,et al. Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB , 1997, Nature.
[57] D. Kono,et al. Quantitative polymerase chain reaction analysis reveals marked overexpression of interleukin-1β, interleukin-10 and interferon-γ mRNA in the lymph nodes of lupus-prone mice , 1995 .
[58] F. Thaiss,et al. TNF alpha induces expression of the chemoattractant cytokine RANTES in cultured mouse mesangial cells. , 1993, Kidney international.
[59] S. McColl,et al. Expression of the cytokine RANTES in human rheumatoid synovial fibroblasts. Differential regulation of RANTES and interleukin-8 genes by inflammatory cytokines. , 1993, The Journal of biological chemistry.
[60] S. Nagata,et al. Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[61] J. Halperin,et al. Membrane signaling by complement C5b-9, the membrane attack complex , 1993, Immunologic research.
[62] N. Copeland,et al. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis , 1992, Nature.
[63] A. Krensky,et al. Isolation and characterization of cDNA from renal tubular epithelium encoding murine Rantes. , 1992, Kidney international.
[64] A. Jevnikar,et al. Antigen presentation by renal tubular epithelial cells. , 1991, Journal of the American Society of Nephrology : JASN.
[65] L. Hebert. The clearance of immune complexes from the circulation of man and other primates. , 1991, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[66] D. Mendrick,et al. Antigen processing and presentation by glomerular visceral epithelium in vitro. , 1991, Kidney international.
[67] L. Glimcher,et al. Intercellular adhesion molecule-1 (ICAM-1) expression is upregulated in autoimmune murine lupus nephritis. , 1990, The American journal of pathology.
[68] R. Taylor,et al. Physiological and pathological aspects of circulating immune complexes. , 1989, Kidney international.
[69] J. M. Boswell,et al. Increased tumor necrosis factor and IL-1 beta gene expression in the kidneys of mice with lupus nephritis. , 1988, Journal of immunology.
[70] J. M. Boswell,et al. Novel and enhanced IL-1 gene expression in autoimmune mice with lupus. , 1988, Journal of immunology.
[71] A. Dalmasso. Complement in the pathophysiology and diagnosis of human diseases. , 1986, Critical reviews in clinical laboratory sciences.
[72] V. Kelley,et al. Increased renal thromboxane production in murine lupus nephritis. , 1986, The Journal of clinical investigation.
[73] A. Theofilopoulos,et al. Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains , 1978, The Journal of experimental medicine.
[74] S. Shuster,et al. Small-bowel changes in dermatitis herpetiformis. , 1966, Lancet.
[75] J. D. Hicks,et al. Cyclophosphamide treatment of kidney disease in (NZB x NZW) F1 mice. , 1966, Lancet.